IMA Q4 2021 Earnings — ImageneBio Inc Revenue & Financial Results | Market Cap Arena

IMAImageneBio Inc

$69M

Q4 2021 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$20M+31003.1% YoY

Gross Profit

$8M39.0% margin

Operating Income

$3M13.8% margin

Net Income

$3M13.8% margin

EPS (Diluted)

$0.08

QoQ Revenue Growth

+439.7%

Cash Flow

Operating Cash Flow

-$13M

Free Cash Flow

-$14M

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$248M

Total Liabilities

$40M

Stockholders' Equity

$208M

Cash & Equivalents

$232M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$20M	$65,000	+31003.1%
Gross Profit	$8M	-$23M	+133.8%
Operating Income	$3M	-$26M	+110.7%
Net Income	$3M	-$26M	+110.7%